Guerbet

Guerbet
Industry Pharmaceutical
Founded 1926
Headquarters Villepinte
Revenue 0.489 billion (2015)
Number of employees
2,500 (2015)
Slogan Contrast for Life
Website www.guerbet.com

Guerbet is a research-centered pharmaceutical company based in France that is one of the major players in the contrast agents business.

The company's main products are:

History

The company is named after the French chemist Marcel Guerbet (1861–1938), who produced Lipiodol in 1901 and his son André Guerbert, who founded the company in 1926. The X-ray contrast properties of Lipiodol were discovered in 1918.

On July 27, 2015, Guerbet announced that it has entered into a definitive agreement under which it will acquire Mallinckrodt’s contrast media and delivery systems business ("CMDS").

On November 27, 2015, Guerbet completed acquisition of Mallinckrodt’s Contrast Media and Delivery Systems business ("CMDS"), for $270M in cash, financed by BNP Paribas.[1]

References

  1. "News". www.guerbet.com. Retrieved 2016-03-21.


This article is issued from Wikipedia - version of the Tuesday, April 26, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.